0 (0%) | 09-27 11:14 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 75 | 1-year : | 87.61 |
Resists | First : | 64.22 | Second : | 75 |
Pivot price | 62.57 ![]() |
|||
Supports | First : | 59.11 | Second : | 55.95 |
MAs | MA(5) : | 62.88 ![]() |
MA(20) : | 62.47 ![]() |
MA(100) : | 57.52 ![]() |
MA(250) : | 59.59 ![]() |
|
MACD | MACD : | 0.9 ![]() |
Signal : | 1 ![]() |
%K %D | K(14,3) : | 57.9 ![]() |
D(3) : | 62.3 ![]() |
RSI | RSI(14): 56.3 ![]() |
|||
52-week | High : | 68.98 | Low : | 51.25 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ UTMD ] has closed below upper band by 40.9%. Bollinger Bands are 40.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 63.43 - 63.81 | 63.81 - 64.18 |
Low: | 61.29 - 61.74 | 61.74 - 62.18 |
Close: | 62.12 - 62.78 | 62.78 - 63.42 |
Tue, 16 Sep 2025
Recap Report: Is UTMD forming a bullish divergence - Weekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Wed, 30 Jul 2025
UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3% - The Globe and Mail
Tue, 29 Jul 2025
Utah Medical Products Boosts Shareholder Returns: Announces 1.7% Dividend Increase for Q3 2025 - Stock Titan
Sun, 27 Jul 2025
What are analysts’ price targets for UTMD in the next 12 months - Invest smarter with actionable market insights - Jammu Links News
Thu, 03 Jul 2025
Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 3 (M) |
Shares Float | 3 (M) |
Held by Insiders | 7.1 (%) |
Held by Institutions | 71.3 (%) |
Shares Short | 110 (K) |
Shares Short P.Month | 111 (K) |
EPS | 3.75 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 36.54 |
Profit Margin | 32.3 % |
Operating Margin | 34.9 % |
Return on Assets (ttm) | 6.9 % |
Return on Equity (ttm) | 10.3 % |
Qtrly Rev. Growth | -4.4 % |
Gross Profit (p.s.) | 6.93 |
Sales Per Share | 12.09 |
EBITDA (p.s.) | 5.25 |
Qtrly Earnings Growth | -4 % |
Operating Cash Flow | 14 (M) |
Levered Free Cash Flow | 11 (M) |
PE Ratio | 16.74 |
PEG Ratio | 0 |
Price to Book value | 1.71 |
Price to Sales | 5.19 |
Price to Cash Flow | 14.26 |
Dividend | 0.31 |
Forward Dividend | 0 |
Dividend Yield | 0.4% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |